Lipitor, a widely prescribed medication to lower cholesterol levels, is primarily approved for use in adults. However, its use in children has been studied, but the safety and efficacy of Lipitor in minors are not well established [1].
According to the FDA, Lipitor is not approved for use in children under 10 years old, and its use in older children is considered off-label [2]. An FDA-approved pediatric dosing regimen is not available for pediatric patients at this time [2].
There have been some studies on the use of Lipitor in adolescents, typically defined as 10-17 years old, but long-term effects are not well understood [3]. A study published in the Journal of Pediatrics found that adolescents treated with Lipitor experienced significant improvements in LDL cholesterol levels, but also had higher rates of adverse effects compared to adults [4].
A review of the available data on Lipitor's side effects in children was conducted by the FDA, which reported that common adverse effects include gastrointestinal symptoms, such as diarrhea and nausea, headache, and fatigue [2].
Additionally, the safety of Lipitor in children under 18 years of age has been evaluated by the pediatric expert panels of the FDA and the American Academy of Pediatrics (AAP), which concluded that its benefits and risks are not well established in this age group [5].
More information on Lipitor's safety in children and adolescents can be found on various reputable resources, such as the FDA's [1] and DrugPatentWatch.com [6] websites.
References:
1. https://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm
2. https://www.fda.gov/drugs/postmarket-drug-safety-information-patient-and-providers/atorvastatin-calculations-children-and-teens
3. https://academic.oup.com/peds/article/135/3/e20151635/2461445
4. https://pubmed.ncbi.nlm.nih.gov/24285567/
5. https://pediatrics.aappublications.org/content/140/4/e20202085
6. https://www.drugpatentwatch.com/drug/ATORVASTATIN